Protocol Service
Peptide Therapy
Ipamorelin Peptide Therapy in Scarsdale, NY
Protocol Health prescribes ipamorelin, a compounded growth hormone secretagogue, at our Scarsdale, NY clinic under physician supervision. It prompts growth hormone release through a different receptor than sermorelin, and its FDA status and safety concerns are explained before you decide.
Consultation $249, or $349 with blood work.
Ipamorelin has never been FDA-approved for any use. The FDA keeps ipamorelin acetate on its list of bulk substances that may present significant safety risks for outsourcing facilities.
Medically reviewed by Richard Dentico, MD, Medical Director
★ 5.0 on Google · 107 reviews (as of October 2026) · Physician-led, family-owned
Our Scarsdale clinic serves Westchester County. Telehealth in NY, NJ, CT, FL and CA.
Book Now
Ipamorelin at Protocol Health
Before you book
What is ipamorelin?
Ipamorelin is a growth hormone secretagogue: it acts on the ghrelin receptor in the pituitary to release growth hormone. Sermorelin and CJC-1295 act on a different receptor, the GHRH receptor, which is why ipamorelin is sometimes paired with CJC-1295. It is not FDA-approved for any use, including anti-aging, recovery or body composition.
For the background on the peptide itself, read our guide to what ipamorelin is and how it works.
Who asks about ipamorelin?
Adults interested in growth hormone-releasing peptides under supervision.
- Interested in GH secretagogues
- Want oversight and labs
- Understand the FDA's concerns
Ipamorelin safety and FDA status
What the FDA has said, in brief.
Status. Never FDA-approved; what US clinics prescribe is compounded.
FDA concerns. Possible immune reactions, hard-to-characterize impurities, and a published report of serious adverse events when given intravenously for gut motility.
Context. In the one controlled trial of that use, overall adverse events were no more common than placebo.
How ipamorelin care works
Evaluation first. A provider reviews goals and history before any prescription.
FDA concerns explained. Including the FDA's safety-risk listing for outsourcing facilities.
Alternatives compared. Sermorelin, CJC-1295 and tesamorelin are weighed at the same visit.
Follow-up. Your provider decides with you whether to continue.
Starting ipamorelin
Consult, labs, decision.
- Consultation. Goals and history.
- Labs. At the Scarsdale clinic or near home.
- Decision. Ipamorelin, an alternative, or nothing.
- Follow-up. Check-ins on response.
Common questions
Ipamorelin: frequently asked questions
Is ipamorelin FDA-approved?
No. Ipamorelin has never been FDA-approved for any use.
How does ipamorelin differ from sermorelin?
Ipamorelin acts on the ghrelin receptor; sermorelin acts on the GHRH receptor. Our sermorelin vs ipamorelin guide compares them.
Why is ipamorelin paired with CJC-1295?
They raise growth hormone through different receptors. The pairing rests on mechanism, not on trials of the combination.
Are there safety concerns?
The FDA lists ipamorelin acetate among bulk substances that may present significant safety risks for outsourcing facilities.
Contact Us
Book Your Appointment Today
Fill out the form below to schedule your visit with our expert team.